LILRB1 antibody blocks the interaction of MHC-I and LILRB1 to increase the phagocytosis capability of macrophages, increase M1/M2 ratio and also improve the cytotoxic capability of both NK and T cells to inhibit tumor growth [96]. Here, LILRB1 is linked to neoplasm.